Tominaga Y
Department of Transplant Surgery, Nagoya 2nd Red Cross Hospital, Japan.
Nephrol Dial Transplant. 1999;14 Suppl 1:63-5. doi: 10.1093/ndt/14.suppl_1.63.
Clonal analysis has shown that in renal hyperparathyroidism (2-HPT), parathyroid glands initially grow diffusely and polyclonally after which the foci of nodular hyperplasia are transformed to monoclonal neoplasia. There is a great deal of information about genetic abnormalities contributing to the tumourigenesis of parathyroid neoplasia in primary hyperparathyroidism. It is speculated that allelic loss of the MEN1 suppressor gene and overexpression of cyclin D1 induced by rearrangement of the parathyroid hormone gene may be the major genetic abnormality in sporadic parathyroid adenoma but not in 2-HPT. The pathogenesis of 2-HPT, abnormality of the Ca2+-sensing receptor (CaR) gene and the vitamin D receptor gene may possibly contribute to parathyroid tumourigenesis in 2-HPT. However, this is not yet clear and heterogeneous and multiple genetic abnormalities may be responsible for the progression of secondary parathyroid hyperplasia.
克隆分析表明,在肾性甲状旁腺功能亢进症(2-HPT)中,甲状旁腺最初呈弥漫性多克隆生长,之后结节性增生灶转变为单克隆肿瘤。关于原发性甲状旁腺功能亢进症中导致甲状旁腺肿瘤发生的遗传异常,已有大量信息。据推测,MEN1抑癌基因的等位基因缺失以及甲状旁腺激素基因重排诱导的细胞周期蛋白D1过表达可能是散发性甲状旁腺腺瘤的主要遗传异常,但在2-HPT中并非如此。2-HPT的发病机制,即钙敏感受体(CaR)基因和维生素D受体基因的异常,可能在2-HPT的甲状旁腺肿瘤发生中起作用。然而,目前尚不清楚,继发性甲状旁腺增生的进展可能是由异质性和多种遗传异常所致。